Tectonic Therapeutic (TECX) Consolidated Net Income (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Consolidated Net Income data on file, last reported at -$53.8 million in Q1 2026.

• On a quarterly basis, Consolidated Net Income fell 236.16% year-over-year to -$53.8 million in Q1 2026; TTM through Mar 2026 was -$112.0 million, a 99.14% decrease from a year earlier, with the FY2025 full-year figure at -$74.2 million, down 33.65% from the prior year.
• Consolidated Net Income for Q1 2026 stood at -$53.8 million, down from -$19.2 million in the prior quarter.
• Over the last five years, Consolidated Net Income for TECX reached as high as -$9.3 million in Q4 2023 and fell as low as -$53.8 million in Q1 2026.
• Historically, Consolidated Net Income has averaged -$20.5 million across 5 years, with a median of -$19.0 million in 2025.
• Across the five-year window, Consolidated Net Income surged 63.69% in 2023 and slumped 236.16% in 2026, its largest moves.
• Year by year, Consolidated Net Income stood at -$25.5 million in 2022, then jumped by 63.68% to -$9.3 million in 2023, then fell by 6.46% to -$9.9 million in 2024, then plunged by 94.71% to -$19.2 million in 2025, then plunged by 179.85% to -$53.8 million in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were -$53.8 million in Q1 2026, -$19.2 million in Q4 2025, and -$19.0 million in Q3 2025.